Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve 1. Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Speciality Medicines Ltd has informed BSE that a Board meeting is scheduled for May 28, 2026 to consider and approve the Audited Standalone Financial Statements and Results for the financial year ended March 31, 2026. The meeting will be held at the Corporate Office in Mumbai. The company has also confirmed that the trading window for insiders has been closed since April 1, 2026 and will reopen 48 hours after the results are approved. This is a standard regulatory intimation under SEBI Listing Regulations.
This is a routine pre-meeting intimation with no material new information. The actual impact on the stock will depend on the financial results to be announced after May 28, 2026. Investors should watch for the results announcement for insights into company performance.